Overview
MLTX market data
Price History
MLTX price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for MLTX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
HC Wainwright & Co. Reiterates Buy on MoonLake, Maintains $45 Price TargetBenzinga · Jul 20, 2026, 11:12 AM
8-K filing — MoonLake Immunotherapeutics (MLTX)SEC EDGAR · Jul 14, 2026, 9:31 PM
MoonLake Immunotherapeutics' CFO Sells 39K SharesThe Motley Fool · Jul 3, 2026, 3:15 PM
Leerink Partners Maintains Outperform on MoonLake, Raises Price Target to $29Benzinga · Jul 1, 2026, 1:30 PM
FedEx, Cerebras Systems And Other Big Stocks Moving Lower In Wednesday’s Pre-Market SessionBenzinga · Jun 24, 2026, 12:05 PM
MoonLake Immunotherapeutics Announces Proposed Public Offering Of $150M Of Its Class A Ordinary SharesBenzinga · Jun 22, 2026, 8:05 PM
Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On MondayBenzinga · Jun 22, 2026, 4:10 PM
Why Is MoonLake Immunotherapeutics Stock Soaring Monday?Benzinga · Jun 22, 2026, 12:05 PM
Moonlake Immunotherapeutics Inks Master Commercial Supply Agreement With Vetter Pharma To Manufacture One Or More Application Systems Pre-filled With An Active Pharmaceutical Ingredient, Placebo Or Other Material For Moonlake-8KBenzinga · Jun 1, 2026, 11:18 AM
FDA Aligns With MoonLake On Lead Drug Submission Plans, Stock SoarsBenzinga · May 11, 2026, 3:44 PM